25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

biote Corp
Buy, Hold or Sell?

Let's analyze Biote together

I guess you are interested in biote Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of biote Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about biote Corp

I send you an email if I find something interesting about biote Corp.

1. Quick Overview

1.1. Quick analysis of Biote (30 sec.)










1.2. What can you expect buying and holding a share of Biote? (30 sec.)

How much money do you get?

How much money do you get?
$0.27
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$-3.93
Expected worth in 1 year
$-6.21
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$-2.01
Return On Investment
-30.1%

For what price can you sell your share?

Current Price per Share
$6.67
Expected price per share
$5.091 - $8.44
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biote (5 min.)




Live pricePrice per Share (EOD)
$6.67
Intrinsic Value Per Share
$16.81 - $20.08
Total Value Per Share
$12.88 - $16.15

2.2. Growth of Biote (5 min.)




Is Biote growing?

Current yearPrevious yearGrowGrow %
How rich?-$126.8m-$66.6m-$20.8m-23.8%

How much money is Biote making?

Current yearPrevious yearGrowGrow %
Making money$2.5m-$1.5m$4m162.1%
Net Profit Margin5.1%-3.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Biote (5 min.)




2.4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  


Richest
#176 / 180

Most Revenue
#120 / 180

Most Profit
#99 / 180
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biote?

Welcome investor! Biote's management wants to use your money to grow the business. In return you get a share of Biote.

First you should know what it really means to hold a share of Biote. And how you can make/lose money.

Speculation

The Price per Share of Biote is $6.67. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biote.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biote, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-3.93. Based on the TTM, the Book Value Change Per Share is $-0.57 per quarter. Based on the YOY, the Book Value Change Per Share is $0.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biote.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.335.0%0.050.8%-0.47-7.1%0.416.2%0.416.2%
Usd Book Value Change Per Share0.355.3%-0.57-8.6%0.477.1%-0.26-3.9%-0.26-3.9%
Usd Dividend Per Share0.132.0%0.071.0%0.071.1%0.081.2%0.081.2%
Usd Total Gains Per Share0.487.2%-0.50-7.5%0.548.1%-0.18-2.7%-0.18-2.7%
Usd Price Per Share5.58-5.95-5.45-6.18-6.18-
Price to Earnings Ratio4.21--4.92--3.14-4.35-4.35-
Price-to-Total Gains Ratio11.57-1.35-4.87-10.40-10.40-
Price to Book Ratio-1.42--4.05--3.01-32.29-32.29-
Price-to-Total Gains Ratio11.57-1.35-4.87-10.40-10.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.67
Number of shares149
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.070.08
Usd Book Value Change Per Share-0.57-0.26
Usd Total Gains Per Share-0.50-0.18
Gains per Quarter (149 shares)-74.83-27.21
Gains per Year (149 shares)-299.31-108.85
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
141-340-30947-156-119
282-680-60895-312-228
3123-1021-907142-469-337
4164-1361-1206189-625-446
5205-1701-1505237-781-555
6246-2041-1804284-937-664
7287-2382-2103331-1093-773
8327-2722-2402379-1250-882
9368-3062-2701426-1406-991
10409-3402-3000474-1562-1100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%6.06.00.050.0%9.06.00.060.0%9.06.00.060.0%9.06.00.060.0%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%9.06.00.060.0%9.06.00.060.0%9.06.00.060.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%15.00.00.0100.0%15.00.00.0100.0%15.00.00.0100.0%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%9.06.00.060.0%9.06.00.060.0%9.06.00.060.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of biote Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.352-0.571+262%0.471-25%-0.262+174%-0.262+174%
Book Value Per Share---3.931-2.522-36%-1.922-51%0.230-1809%0.230-1809%
Current Ratio--1.5053.275-54%5.164-71%6.435-77%6.435-77%
Debt To Asset Ratio--2.2531.823+24%1.524+48%1.294+74%1.294+74%
Debt To Equity Ratio----0%-0%2.484-100%2.484-100%
Dividend Per Share--0.1300.069+90%0.071+84%0.079+64%0.079+64%
Enterprise Value---9835685.78078446374.140-113%84017794.808-112%230090014.414-104%230090014.414-104%
Eps--0.3320.051+554%-0.475+243%0.414-20%0.414-20%
Ev To Ebitda Ratio---0.202-4.446+2103%2.475-108%6.592-103%6.592-103%
Ev To Sales Ratio---0.0480.424-111%0.458-110%1.495-103%1.495-103%
Free Cash Flow Per Share--0.4560.237+93%0.171+167%0.127+258%0.127+258%
Free Cash Flow To Equity Per Share--0.401-0.272+168%0.059+584%0.073+452%0.073+452%
Gross Profit Margin--1.0000.071+1300%0.975+3%0.716+40%0.716+40%
Intrinsic Value_10Y_max--20.076--------
Intrinsic Value_10Y_min--16.811--------
Intrinsic Value_1Y_max--0.641--------
Intrinsic Value_1Y_min--0.629--------
Intrinsic Value_3Y_max--2.970--------
Intrinsic Value_3Y_min--2.814--------
Intrinsic Value_5Y_max--6.559--------
Intrinsic Value_5Y_min--5.998--------
Market Cap207521709.000+13%180015314.220235207124.140-23%195336044.808-8%312809102.253-42%312809102.253-42%
Net Profit Margin--0.2080.051+307%-0.032+115%0.129+61%0.129+61%
Operating Margin--0.2210.067+232%0.170+30%-0.006+103%-0.006+103%
Operating Ratio--0.7630.798-4%0.834-9%0.927-18%0.927-18%
Pb Ratio-1.697-20%-1.419-4.050+185%-3.009+112%32.290-104%32.290-104%
Pe Ratio5.027+16%4.205-4.925+217%-3.135+175%4.349-3%4.349-3%
Price Per Share6.670+16%5.5805.948-6%5.450+2%6.182-10%6.182-10%
Price To Free Cash Flow Ratio3.660+16%3.0628.213-63%-25.171+922%1.286+138%1.286+138%
Price To Total Gains Ratio13.834+16%11.5731.355+754%4.868+138%10.402+11%10.402+11%
Quick Ratio--1.0042.421-59%4.845-79%4.466-78%4.466-78%
Return On Assets--0.1060.019+467%-0.013+112%0.044+142%0.044+142%
Return On Equity----0%-0%0.307-100%0.307-100%
Total Gains Per Share--0.482-0.502+204%0.542-11%-0.183+138%-0.183+138%
Usd Book Value---126824000.000-87480250.000-31%-66646500.000-47%3153548.067-4122%3153548.067-4122%
Usd Book Value Change Per Share--0.352-0.571+262%0.471-25%-0.262+174%-0.262+174%
Usd Book Value Per Share---3.931-2.522-36%-1.922-51%0.230-1809%0.230-1809%
Usd Dividend Per Share--0.1300.069+90%0.071+84%0.079+64%0.079+64%
Usd Enterprise Value---9835685.78078446374.140-113%84017794.808-112%230090014.414-104%230090014.414-104%
Usd Eps--0.3320.051+554%-0.475+243%0.414-20%0.414-20%
Usd Free Cash Flow--14698000.0008516750.000+73%5989500.000+145%4943933.333+197%4943933.333+197%
Usd Free Cash Flow Per Share--0.4560.237+93%0.171+167%0.127+258%0.127+258%
Usd Free Cash Flow To Equity Per Share--0.401-0.272+168%0.059+584%0.073+452%0.073+452%
Usd Market Cap207521709.000+13%180015314.220235207124.140-23%195336044.808-8%312809102.253-42%312809102.253-42%
Usd Price Per Share6.670+16%5.5805.948-6%5.450+2%6.182-10%6.182-10%
Usd Profit--10702000.0002511000.250+326%-1558500.000+115%5093452.000+110%5093452.000+110%
Usd Revenue--51384000.00048265000.000+6%46035500.000+12%40394666.667+27%40394666.667+27%
Usd Total Gains Per Share--0.482-0.502+204%0.542-11%-0.183+138%-0.183+138%
 EOD+5 -3MRQTTM+24 -14YOY+18 -205Y+23 -1710Y+23 -17

3.3 Fundamental Score

Let's check the fundamental score of biote Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-155.027
Price to Book Ratio (EOD)Between0-1-1.697
Net Profit Margin (MRQ)Greater than00.208
Operating Margin (MRQ)Greater than00.221
Quick Ratio (MRQ)Greater than11.004
Current Ratio (MRQ)Greater than11.505
Debt to Asset Ratio (MRQ)Less than12.253
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.106
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of biote Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.942
Ma 20Greater thanMa 506.319
Ma 50Greater thanMa 1005.686
Ma 100Greater thanMa 2006.042
OpenGreater thanClose6.470
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About biote Corp

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

Fundamental data was last updated by Penke on 2024-12-04 06:44:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biote earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biote to the Medical Care Facilities industry mean.
  • A Net Profit Margin of 20.8% means that $0.21 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of biote Corp:

  • The MRQ is 20.8%. The company is making a huge profit. +2
  • The TTM is 5.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ20.8%TTM5.1%+15.7%
TTM5.1%YOY-3.2%+8.3%
TTM5.1%5Y12.9%-7.8%
5Y12.9%10Y12.9%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ20.8%4.5%+16.3%
TTM5.1%3.2%+1.9%
YOY-3.2%2.4%-5.6%
5Y12.9%3.1%+9.8%
10Y12.9%3.3%+9.6%
4.3.1.2. Return on Assets

Shows how efficient Biote is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biote to the Medical Care Facilities industry mean.
  • 10.6% Return on Assets means that Biote generated $0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of biote Corp:

  • The MRQ is 10.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 1.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.6%TTM1.9%+8.7%
TTM1.9%YOY-1.3%+3.2%
TTM1.9%5Y4.4%-2.5%
5Y4.4%10Y4.4%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ10.6%1.2%+9.4%
TTM1.9%1.1%+0.8%
YOY-1.3%0.6%-1.9%
5Y4.4%1.0%+3.4%
10Y4.4%1.0%+3.4%
4.3.1.3. Return on Equity

Shows how efficient Biote is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biote to the Medical Care Facilities industry mean.
  • 0.0% Return on Equity means Biote generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of biote Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y30.7%-30.7%
5Y30.7%10Y30.7%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.1%-3.1%
TTM-2.8%-2.8%
YOY-2.0%-2.0%
5Y30.7%2.4%+28.3%
10Y30.7%2.6%+28.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of biote Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biote is operating .

  • Measures how much profit Biote makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biote to the Medical Care Facilities industry mean.
  • An Operating Margin of 22.1% means the company generated $0.22  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of biote Corp:

  • The MRQ is 22.1%. The company is operating efficient. +1
  • The TTM is 6.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ22.1%TTM6.7%+15.5%
TTM6.7%YOY17.0%-10.3%
TTM6.7%5Y-0.6%+7.2%
5Y-0.6%10Y-0.6%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ22.1%8.1%+14.0%
TTM6.7%6.8%-0.1%
YOY17.0%7.9%+9.1%
5Y-0.6%6.9%-7.5%
10Y-0.6%7.7%-8.3%
4.3.2.2. Operating Ratio

Measures how efficient Biote is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 0.76 means that the operating costs are $0.76 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of biote Corp:

  • The MRQ is 0.763. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.798. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.763TTM0.798-0.035
TTM0.798YOY0.834-0.036
TTM0.7985Y0.927-0.129
5Y0.92710Y0.9270.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7631.000-0.237
TTM0.7981.039-0.241
YOY0.8340.995-0.161
5Y0.9271.008-0.081
10Y0.9270.983-0.056
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of biote Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biote is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 1.50 means the company has $1.50 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of biote Corp:

  • The MRQ is 1.505. The company is able to pay all its short-term debts. +1
  • The TTM is 3.275. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.505TTM3.275-1.770
TTM3.275YOY5.164-1.889
TTM3.2755Y6.435-3.159
5Y6.43510Y6.4350.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5051.246+0.259
TTM3.2751.263+2.012
YOY5.1641.319+3.845
5Y6.4351.375+5.060
10Y6.4351.426+5.009
4.4.3.2. Quick Ratio

Measures if Biote is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biote to the Medical Care Facilities industry mean.
  • A Quick Ratio of 1.00 means the company can pay off $1.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of biote Corp:

  • The MRQ is 1.004. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 2.421. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.004TTM2.421-1.416
TTM2.421YOY4.845-2.424
TTM2.4215Y4.466-2.046
5Y4.46610Y4.4660.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0040.730+0.274
TTM2.4210.797+1.624
YOY4.8451.030+3.815
5Y4.4661.161+3.305
10Y4.4661.174+3.292
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of biote Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biote assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biote to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 2.25 means that Biote assets are financed with 225.3% credit (debt) and the remaining percentage (100% - 225.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of biote Corp:

  • The MRQ is 2.253. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.823. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.253TTM1.823+0.429
TTM1.823YOY1.524+0.300
TTM1.8235Y1.294+0.529
5Y1.29410Y1.2940.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2530.519+1.734
TTM1.8230.522+1.301
YOY1.5240.524+1.000
5Y1.2940.545+0.749
10Y1.2940.530+0.764
4.5.4.2. Debt to Equity Ratio

Measures if Biote is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biote to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of biote Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y2.484-2.484
5Y2.48410Y2.4840.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.943-0.943
TTM-0.950-0.950
YOY-0.976-0.976
5Y2.4841.133+1.351
10Y2.4841.194+1.290
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biote generates.

  • Above 15 is considered overpriced but always compare Biote to the Medical Care Facilities industry mean.
  • A PE ratio of 4.21 means the investor is paying $4.21 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of biote Corp:

  • The EOD is 5.027. Based on the earnings, the company is cheap. +2
  • The MRQ is 4.205. Based on the earnings, the company is cheap. +2
  • The TTM is -4.925. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5.027MRQ4.205+0.821
MRQ4.205TTM-4.925+9.130
TTM-4.925YOY-3.135-1.790
TTM-4.9255Y4.349-9.274
5Y4.34910Y4.3490.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD5.02712.889-7.862
MRQ4.20512.736-8.531
TTM-4.92513.741-18.666
YOY-3.13513.820-16.955
5Y4.34916.490-12.141
10Y4.34920.773-16.424
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of biote Corp:

  • The EOD is 3.660. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.062. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.213. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.660MRQ3.062+0.598
MRQ3.062TTM8.213-5.151
TTM8.213YOY-25.171+33.385
TTM8.2135Y1.286+6.927
5Y1.28610Y1.2860.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD3.6608.901-5.241
MRQ3.0629.248-6.186
TTM8.2137.040+1.173
YOY-25.1717.380-32.551
5Y1.2866.597-5.311
10Y1.2866.206-4.920
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biote is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of -1.42 means the investor is paying $-1.42 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of biote Corp:

  • The EOD is -1.697. Based on the equity, the company is expensive. -2
  • The MRQ is -1.419. Based on the equity, the company is expensive. -2
  • The TTM is -4.050. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.697MRQ-1.419-0.277
MRQ-1.419TTM-4.050+2.630
TTM-4.050YOY-3.009-1.040
TTM-4.0505Y32.290-36.339
5Y32.29010Y32.2900.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-1.6971.670-3.367
MRQ-1.4191.868-3.287
TTM-4.0501.978-6.028
YOY-3.0092.185-5.194
5Y32.2902.357+29.933
10Y32.2902.757+29.533
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of biote Corp.

4.8.1. Institutions holding biote Corp

Institutions are holding 64.605% of the shares of biote Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30325 Capital LLC14.618310.7451454812778146120.7468
2024-09-30Bandera Partners LLC7.82845.1303243563500
2024-06-30BlackRock Inc5.15880.0003160502863219464.9848
2024-09-30Vanguard Group Inc4.5570.00011417793368932.6717
2024-09-30Wasatch Advisors LP4.47670.038113928091077928.3884
2024-09-30Dimensional Fund Advisors, Inc.2.18070.0009678459183902.7861
2024-09-30Boston Partners Global Investors, Inc1.97780.0041615337-54391-8.1214
2024-09-30Geode Capital Management, LLC1.79670.0003558989-59216-9.5787
2024-09-30SW Investment Management LLC1.60710.7375500000-500000-50
2024-09-30State Street Corp1.52830.00014754915729013.6992
2024-09-30GlobeFlex Capital, L.P.0.87550.14562724002724000
2024-09-30Jacobs Levy Equity Management, Inc.0.87550.00592723775430224.9006
2024-09-30Northern Trust Corp0.84360.000226246310414465.7811
2024-09-30Skylands Capital, LLC0.6380.15031985003765523.4107
2024-09-30SMH Capital Inc.0.58160.1675180965102706131.2386
2024-09-30Renaissance Technologies Corp0.52380.0014162977-30100-15.5896
2024-09-30Morgan Stanley - Brokerage Accounts0.44880.0001139633-58219-29.4255
2024-09-30Goldman Sachs Group Inc0.3360.00011045481085811.5893
2024-09-30Brandywine Global Investment Mgmt LLC0.29410.0032914974438394.2034
2024-09-30Two Sigma Investments LLC0.28930.001190023-36772-29.0011
Total 51.43617.132216003051+1521770+9.5%

4.9.2. Funds holding biote Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31Vanguard Total Stock Mkt Idx Inv2.75320.000385660300
2024-11-27iShares Russell 2000 ETF2.32940.006724726-1512-0.2082
2024-09-30Wasatch Micro Cap Value1.97031.0394613010392216.8354
2024-09-30Boston Partners Small Cap Value II Inv1.58730.4885493862-32923-6.2498
2024-03-31Philotimo Focused Growth and Income1.34342.6564417964290767.4767
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr1.09950.001634207100
2024-09-30Fidelity Small Cap Index0.86280.0055268454-2086-0.7711
2024-11-27iShares Russell 2000 Growth ETF0.71560.011122265500
2024-09-30DFA US Small Cap I0.59830.006218614200
2024-09-30DFA US Micro Cap I0.56170.012717476300
2024-09-30Fidelity Extended Market Index0.41470.0017129029-34343-21.0214
2024-10-31Vanguard Russell 2000 ETF0.39610.0051123227-770-0.621
2024-10-31State St Russell Sm Cap® Indx SL Cl I0.37570.006211690000
2024-10-31State St Russell Sm/Mid Cp® Indx NL Cl C0.33620.0012104586-5500-4.9961
2024-11-28Dimensional US Small Cap ETF0.31280.00669732400
2024-11-28First Trust Dow Jones Sel MicroCap ETF0.23050.25377170500
2024-11-27iShares Micro-Cap ETF0.20630.0436417000
2024-09-30NT R2000 Index Fund - NL0.20560.0054639732989387.7142
2024-10-31Schwab Small Cap Index0.20380.00516340800
2024-09-30American Beacon Small Cp Val R50.19980.00762150-807-1.2818
Total 16.7034.56275196722+20249+0.4%

5.3. Insider Transactions

Insiders are holding 27.6% of the shares of biote Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-07-09Robert Charles PetersonSELL113767.57
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Net Debt  50,724-24,85525,8699,18735,05660,91095,966-124,433-28,467



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets101,252
Total Liabilities228,076
Total Stockholder Equity-126,824
 As reported
Total Liabilities 228,076
Total Stockholder Equity+ -126,824
Total Assets = 101,252

Assets

Total Assets101,252
Total Current Assets69,983
Long-term Assets31,269
Total Current Assets
Cash And Cash Equivalents 38,225
Net Receivables 8,493
Inventory 16,200
Other Current Assets 7,065
Total Current Assets  (as reported)69,983
Total Current Assets  (calculated)69,983
+/-0
Long-term Assets
Property Plant Equipment 9,189
Goodwill 5,516
Intangible Assets 5,666
Long-term Assets Other 4,974
Long-term Assets  (as reported)31,269
Long-term Assets  (calculated)25,345
+/- 5,924

Liabilities & Shareholders' Equity

Total Current Liabilities46,510
Long-term Liabilities181,566
Total Stockholder Equity-126,824
Total Current Liabilities
Short-term Debt 6,732
Short Long Term Debt 6,250
Accounts payable 4,374
Other Current Liabilities 32,271
Total Current Liabilities  (as reported)46,510
Total Current Liabilities  (calculated)49,627
+/- 3,117
Long-term Liabilities
Long term Debt 112,548
Capital Lease Obligations 3,508
Long-term Liabilities Other 64,389
Long-term Liabilities  (as reported)181,566
Long-term Liabilities  (calculated)180,445
+/- 1,121
Total Stockholder Equity
Common Stock4
Retained Earnings -124,717
Accumulated Other Comprehensive Income -29
Other Stockholders Equity -2,082
Total Stockholder Equity (as reported)-126,824
Total Stockholder Equity (calculated)-126,824
+/-0
Other
Capital Stock4
Cash and Short Term Investments 38,225
Common Stock Shares Outstanding 32,261
Current Deferred Revenue2,927
Liabilities and Stockholders Equity 101,252
Net Debt -28,467
Net Invested Capital -11,544
Net Working Capital 23,473
Property Plant and Equipment Gross 15,289
Short Long Term Debt Total 9,758



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-31
> Total Assets 
0
319,015
318,449
318,234
54,330
54,330
115,322
109,578
111,645
119,135
139,052
149,749
155,295
160,108
92,900
101,252
101,25292,900160,108155,295149,749139,052119,135111,645109,578115,32254,33054,330318,234318,449319,0150
   > Total Current Assets 
27,822
1,500
759
685
47,085
47,085
106,298
100,811
101,178
107,456
112,110
117,753
122,343
114,361
61,767
69,983
69,98361,767114,361122,343117,753112,110107,456101,178100,811106,29847,08547,0856857591,50027,822
       Cash And Cash Equivalents 
0
922
484
295
26,766
26,766
82,725
77,461
79,231
87,608
68,480
65,575
89,002
78,787
26,419
38,225
38,22526,41978,78789,00265,57568,48087,60879,23177,46182,72526,76626,7662954849220
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
20,000
20,000
0
0
0
0
000020,00020,0000000000000
       Net Receivables 
4,720
0
0
0
5,231
5,231
6,823
7,635
6,948
7,646
8,336
10,177
6,809
8,022
8,589
8,493
8,4938,5898,0226,80910,1778,3367,6466,9487,6356,8235,2315,2310004,720
       Inventory 
4,324
0
0
0
9,615
9,615
9,812
10,181
11,183
9,623
7,396
11,078
20,945
23,872
23,737
16,200
16,20023,73723,87220,94511,0787,3969,62311,18310,1819,8129,6159,6150004,324
   > Long-term Assets 
0
317,514
317,690
317,549
7,245
7,245
9,024
8,767
10,467
11,679
26,942
31,996
32,952
45,747
31,133
31,269
31,26931,13345,74732,95231,99626,94211,67910,4678,7679,0247,2457,245317,549317,690317,5140
       Property Plant Equipment 
2,165
0
0
0
2,691
2,691
2,319
1,957
3,556
3,290
2,977
3,306
3,095
4,393
6,625
9,189
9,1896,6254,3933,0953,3062,9773,2903,5561,9572,3192,6912,6910002,165
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
5,525
5,516
5,516
5,5165,5165,5250000000000000
       Intangible Assets 
0
0
0
0
4,554
4,554
5,012
5,118
5,073
5,206
5,733
5,449
4,973
10,945
10,851
5,666
5,66610,85110,9454,9735,4495,7335,2065,0735,1185,0124,5544,5540000
       Other Assets 
0
0
0
0
0
0
1,693
1,692
1,838
0
18,232
0
0
0
0
0
0000018,23201,8381,6921,693000000
> Total Liabilities 
0
39,157
25,397
22,186
50,205
50,205
218,833
219,465
169,919
202,944
212,290
201,014
191,841
205,008
234,551
228,076
228,076234,551205,008191,841201,014212,290202,944169,919219,465218,83350,20550,20522,18625,39739,1570
   > Total Current Liabilities 
11,710
59
49
80
17,313
17,313
32,939
22,393
18,766
19,860
21,734
25,083
22,215
24,057
46,266
46,510
46,51046,26624,05722,21525,08321,73419,86018,76622,39332,93917,31317,31380495911,710
       Short-term Debt 
0
0
0
0
0
5,248
6,502
6,440
6,415
6,467
6,530
6,548
6,872
7,062
7,088
6,732
6,7327,0887,0626,8726,5486,5306,4676,4156,4406,5025,24800000
       Short Long Term Debt 
0
0
0
0
5,000
5,000
6,250
6,250
6,250
6,250
6,250
6,250
6,250
6,250
6,250
6,250
6,2506,2506,2506,2506,2506,2506,2506,2506,2506,2505,0005,0000000
       Accounts payable 
2,445
1
0
0
4,349
4,349
8,314
8,245
4,112
5,063
7,468
5,694
4,155
4,196
5,793
4,374
4,3745,7934,1964,1555,6947,4685,0634,1128,2458,3144,3494,3490012,445
       Other Current Liabilities 
2,044
58
0
80
1,705
6,011
16,268
5,719
6,274
6,252
5,426
4,585
8,169
8,788
30,226
32,271
32,27130,2268,7888,1694,5855,4266,2526,2745,71916,2686,0111,705800582,044
   > Long-term Liabilities 
0
39,098
25,348
22,107
32,892
32,892
185,894
197,072
151,153
183,084
190,556
175,931
169,626
180,951
188,285
181,566
181,566188,285180,951169,626175,931190,556183,084151,153197,072185,89432,89232,89222,10725,34839,0980
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
110,719
109,352
0
0
0
0
0
00000109,352110,719000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
375
-4,934
-6,250
-6,250
-4,323
-4,395
-4,469
-4,489
-4,881
-4,739
-4,862
-3,224
-3,224-4,862-4,739-4,881-4,489-4,469-4,395-4,323-6,250-6,250-4,9343750000
       Long-term Liabilities Other 
0
0
0
0
0
0
64,399
78,080
32,110
14,845
17,284
64,998
59,994
72,338
71,025
64,389
64,38971,02572,33859,99464,99817,28414,84532,11078,08064,399000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
57,520
63,920
0
0
0
0
0
0000063,92057,520000000000
> Total Stockholder Equity
0
5,000
5,000
-21,452
4,125
4,125
-24,950
-37,178
-44,459
-48,538
-46,405
-40,529
-29,397
-35,399
-143,341
-126,824
-126,824-143,341-35,399-29,397-40,529-46,405-48,538-44,459-37,178-24,9504,1254,125-21,4525,0005,0000
   Common Stock
0
274,859
288,053
317,501
0
317,500
7
6
6
6
6
6
6
6
4
4
4466666667317,5000317,501288,053274,8590
   Retained Earnings Total Equity00000-46,393-48,532000000000
   Accumulated Other Comprehensive Income -29-22-14-12-13-18-12-5-6-5-4000000
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity -2,082-5,600-4,08800-26,830-35,267-13,810-72,704-78,556-317,500-40-317,500-288,052-265,915-23



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue185,360
Cost of Revenue-57,877
Gross Profit127,483127,483
 
Operating Income (+$)
Gross Profit127,483
Operating Expense-98,826
Operating Income28,65728,657
 
Operating Expense (+$)
Research Development0
Selling General Administrative93,420
Selling And Marketing Expenses0
Operating Expense98,82693,420
 
Net Interest Income (+$)
Interest Income0
Interest Expense-6,363
Other Finance Cost-1,071
Net Interest Income-7,434
 
Pretax Income (+$)
Operating Income28,657
Net Interest Income-7,434
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-12357,437
EBIT - interestExpense = -123
5,998
9,679
Interest Expense6,363
Earnings Before Interest and Taxes (EBIT)6,2406,240
Earnings Before Interest and Taxes (EBITDA)9,234
 
After tax Income (+$)
Income Before Tax-123
Tax Provision-5,862
Net Income From Continuing Ops-2,074-5,985
Net Income3,316
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses156,703
Total Other Income/Expenses Net-28,7807,434
 

Technical Analysis of Biote
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biote. The general trend of Biote is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biote's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of biote Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.98 < 7.17 < 8.44.

The bearish price targets are: 5.49 > 5.25 > 5.091.

Tweet this
biote Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of biote Corp. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

biote Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of biote Corp. The current macd is 0.26888073.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biote price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biote. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biote price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
biote Corp Daily Moving Average Convergence/Divergence (MACD) Chartbiote Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of biote Corp. The current adx is 20.12.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biote shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
biote Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of biote Corp. The current sar is 6.26582099.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
biote Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of biote Corp. The current rsi is 58.94. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
biote Corp Daily Relative Strength Index (RSI) Chartbiote Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of biote Corp. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biote price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
biote Corp Daily Stochastic Oscillator Chartbiote Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of biote Corp. The current cci is 70.59.

biote Corp Daily Commodity Channel Index (CCI) Chartbiote Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of biote Corp. The current cmo is 19.06.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
biote Corp Daily Chande Momentum Oscillator (CMO) Chartbiote Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of biote Corp. The current willr is -26.05042017.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biote is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
biote Corp Daily Williams %R Chartbiote Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of biote Corp.

biote Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of biote Corp. The current atr is 0.35473541.

biote Corp Daily Average True Range (ATR) Chartbiote Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of biote Corp. The current obv is 6,801,118.

biote Corp Daily On-Balance Volume (OBV) Chartbiote Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of biote Corp. The current mfi is 70.90.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
biote Corp Daily Money Flow Index (MFI) Chartbiote Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for biote Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

biote Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of biote Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.942
Ma 20Greater thanMa 506.319
Ma 50Greater thanMa 1005.686
Ma 100Greater thanMa 2006.042
OpenGreater thanClose6.470
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biote with someone you think should read this too:
  • Are you bullish or bearish on Biote? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biote? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about biote Corp

I send you an email if I find something interesting about biote Corp.


Comments

How you think about this?

Leave a comment

Stay informed about biote Corp.

Receive notifications about biote Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.